Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, is a chronic bowel disease characterized by recurrent and persistent symptoms, and its incidence is increasing globally. Previously, it was believed that IBD was triggered by factors that negatively affect the immune system. However, recent evidence suggests that environmental factors, particularly diet, may play a role in the development and prognosis of IBD. Therefore, it is crucial to provide guidance to physicians and patients regarding foods that may have harmful, beneficial, or neutral effects.
For patients with Crohn's disease (CD), it is recommended to consume fruits and vegetables (unless there are strictures present), while reducing the intake of saturated fats, trans fats, dairy fats, and additives such as P80 and carboxymethylcellulose. Additionally, processed dairy products, foods rich in maltodextrin, artificial sweeteners containing sucralose or saccharin, and processed foods with nanoparticles should be avoided. And for patients with ulcerative colitis (UC), it is advised to increase the intake of omega-3 fatty acids from natural sources (e.g., wild salmon), rather than relying solely on supplements. During IBD exacerbation, a low-fiber diet is unquestionably recommended. However, nutritional recommendations for the remission phase of IBD remain controversial. Further research is needed to better understand the effects and mechanisms of diet and nutritional factors in different situations and for various individuals.
There is growing evidence suggesting that various nutritional factors are associated with the development and prognosis of IBD. However, the concept of nutrition encompasses a wide range of factors, including nutrient composition and treatments. Therefore, nutrition strategies are an ongoing dilemma for IBD patients. Consequently, the objective of this research collection is to provide a comprehensive overview of the nutritional factors involved in the development and prognosis of IBD. It aims to include diverse and interesting findings on nutrition, as well as profound approaches, base research, and clinical studies. Original articles, systematic reviews, meta-analyses, and other types of papers are all welcome. By doing so, we aim to clarify the impact of nutrition on IBD and promote the exploration of effective strategies to address the nutritional challenges faced by IBD patients.
This Research Topic welcomes all types of paper, the scope includes but not is limited to the following topics:
• Effects of different dietary patterns in the development and prognosis of IBD
• Effects of nutrients in the development and prognosis of IBD
• Effects of food groups in the development and prognosis of IBD
• Nutritional strategies for IBD at different stages (active and remission)
• Special nutritional strategies in pediatric IBD
• The role of precision nutrition for IBD patients
• Effects of enteral nutrition in the development and prognosis of IBD
• Different nutrition strategies between Crohn’s disease and ulcerative colitis
Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis, is a chronic bowel disease characterized by recurrent and persistent symptoms, and its incidence is increasing globally. Previously, it was believed that IBD was triggered by factors that negatively affect the immune system. However, recent evidence suggests that environmental factors, particularly diet, may play a role in the development and prognosis of IBD. Therefore, it is crucial to provide guidance to physicians and patients regarding foods that may have harmful, beneficial, or neutral effects.
For patients with Crohn's disease (CD), it is recommended to consume fruits and vegetables (unless there are strictures present), while reducing the intake of saturated fats, trans fats, dairy fats, and additives such as P80 and carboxymethylcellulose. Additionally, processed dairy products, foods rich in maltodextrin, artificial sweeteners containing sucralose or saccharin, and processed foods with nanoparticles should be avoided. And for patients with ulcerative colitis (UC), it is advised to increase the intake of omega-3 fatty acids from natural sources (e.g., wild salmon), rather than relying solely on supplements. During IBD exacerbation, a low-fiber diet is unquestionably recommended. However, nutritional recommendations for the remission phase of IBD remain controversial. Further research is needed to better understand the effects and mechanisms of diet and nutritional factors in different situations and for various individuals.
There is growing evidence suggesting that various nutritional factors are associated with the development and prognosis of IBD. However, the concept of nutrition encompasses a wide range of factors, including nutrient composition and treatments. Therefore, nutrition strategies are an ongoing dilemma for IBD patients. Consequently, the objective of this research collection is to provide a comprehensive overview of the nutritional factors involved in the development and prognosis of IBD. It aims to include diverse and interesting findings on nutrition, as well as profound approaches, base research, and clinical studies. Original articles, systematic reviews, meta-analyses, and other types of papers are all welcome. By doing so, we aim to clarify the impact of nutrition on IBD and promote the exploration of effective strategies to address the nutritional challenges faced by IBD patients.
This Research Topic welcomes all types of paper, the scope includes but not is limited to the following topics:
• Effects of different dietary patterns in the development and prognosis of IBD
• Effects of nutrients in the development and prognosis of IBD
• Effects of food groups in the development and prognosis of IBD
• Nutritional strategies for IBD at different stages (active and remission)
• Special nutritional strategies in pediatric IBD
• The role of precision nutrition for IBD patients
• Effects of enteral nutrition in the development and prognosis of IBD
• Different nutrition strategies between Crohn’s disease and ulcerative colitis